DalCor Pharmaceuticals raised $100M Series B venture round, led by Andre Desmarais.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
Andre DesmaraisLEAD | Angel | Andre Desmarais |
| Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$180M
Top Valuation
-
DalCor Pharmaceuticals raised $100M in a Series B round.
The round was announced on 04/19/16.
The round was led by Andre Desmarais, Sanderling Ventures.